Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART Clozapine-Based Sequential Treatment in Treatment-Resistant Schizophrenia
ChiCTR2000036891Phase 4Not yet recruiting
- Sponsor
- Shanghai Mental Health Center
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in schizophrenia comparing Clozapine monotherapy with Clozapine plus amisulpride (2 arms). Primary endpoint: Response rate. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
clozapineamisulpride
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR2000036891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036891.